All Professionals
Overview
Mark Cramer is an associate in the corporate practice of Paul Hastings and is based in the firm's Palo Alto office. He focuses on strategic and private equity mergers and acquisitions, minority and venture capital investments, and corporate governance. Mark routinely advises public and private companies in the fintech, software, biotechnology/biopharmaceutical, and aerospace/defense industries.
Mark is admitted to practice in California and Delaware.
Education
- William & Mary Law School, J.D., 2016
- The Johns Hopkins University, B.A., 2010
Representations
- sbe in its global launch of The Estate by sbe and related strategic partnerships and equity investments.
- sbe in connection with its HQ platform and related strategic partnerships and equity investments.
- Hummingbird Regtech in its acquisition of certain assets from LogicLoop.
- Aardvark Therapeutics in its acquisition of certain assets from MEI Pharma, Inc.
- Hanwha Systems and Hanwha Ocean in its acquisition of Philly Shipyard.
- Predicate Labs, developer of the cryptography software Mir Protocol, in its sale to Polygon.
- A diversified global asset manager in connection with multiple venture capital and growth equity transactions in the cybersecurity, artificial intelligence and sports analytics industries.
- CareDx in its acquisitions of: TransChart, an electronic medical record software provider; and The Transplant Pharmacy, a specialty transplant-focused pharmacy.
- Sorrento Therapeutics in its acquisitions of: Virex Health, a diagnostic platform developer; ACEA Therapeutics, a late-stage oncology drug developer; and SmartPharm Therapeutics, a gene-encoded therapeutics company.
- Symphony Technology Group in its acquisition of CAI Software, a mission-critical software provider to manufacturers and distributors, and related add-on acquisitions.
- Abry Partners and LINK Mobility in connection with the acquisition and later sale of Message Broadcast.